vs
Side-by-side financial comparison of BIOMERICA INC (BMRA) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.
BIOMERICA INC is the larger business by last-quarter revenue ($1.2M vs $919.3K, roughly 1.3× Laser Photonics Corp). BIOMERICA INC runs the higher net margin — -109.1% vs -506.4%, a 397.3% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs -26.0%). Over the past eight quarters, Laser Photonics Corp's revenue compounded faster (-3.9% CAGR vs -12.1%).
Biomerica Inc. is a global medical technology company that develops, manufactures and markets diagnostic test kits and related medical products. Its portfolio covers gastrointestinal conditions, infectious diseases, food intolerances and point-of-care testing solutions, serving clinical labs, healthcare providers and retail healthcare segments across North America, Europe and Asia.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
BMRA vs LASE — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $919.3K |
| Net Profit | $-1.3M | $-4.7M |
| Gross Margin | 4.2% | -20.1% |
| Operating Margin | -113.5% | -350.0% |
| Net Margin | -109.1% | -506.4% |
| Revenue YoY | -26.0% | 28.3% |
| Net Profit YoY | -38.9% | -186.5% |
| EPS (diluted) | $-0.45 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2M | — | ||
| Q3 25 | $1.4M | $919.3K | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | $1.1M | $2.3M | ||
| Q4 24 | $1.6M | $1.3M | ||
| Q3 24 | $1.8M | $716.7K | ||
| Q2 24 | $1.1M | $623.4K | ||
| Q1 24 | $1.0M | $743.0K |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $2.0K | $-4.7M | ||
| Q2 25 | — | $-1.8M | ||
| Q1 25 | $-1.2M | $-1.7M | ||
| Q4 24 | $-950.0K | $586.4K | ||
| Q3 24 | $-1.3M | $-1.6M | ||
| Q2 24 | $-1.4M | $-934.3K | ||
| Q1 24 | $-1.9M | $-545.7K |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 30.7% | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | 1.7% | 49.8% | ||
| Q4 24 | 26.7% | 13.3% | ||
| Q3 24 | 16.0% | 85.0% | ||
| Q2 24 | 2.1% | 50.6% | ||
| Q1 24 | -14.7% | 51.9% |
| Q4 25 | -113.5% | — | ||
| Q3 25 | -81.0% | -350.0% | ||
| Q2 25 | — | -37.0% | ||
| Q1 25 | -108.1% | -68.7% | ||
| Q4 24 | -60.7% | -255.1% | ||
| Q3 24 | -75.7% | -238.0% | ||
| Q2 24 | -136.6% | -149.4% | ||
| Q1 24 | -196.7% | -73.8% |
| Q4 25 | -109.1% | — | ||
| Q3 25 | 0.1% | -506.4% | ||
| Q2 25 | — | -68.3% | ||
| Q1 25 | -103.9% | -73.4% | ||
| Q4 24 | -58.1% | 45.7% | ||
| Q3 24 | -72.8% | -226.8% | ||
| Q2 24 | -127.1% | -149.9% | ||
| Q1 24 | -188.6% | -73.4% |
| Q4 25 | $-0.45 | — | ||
| Q3 25 | $0.00 | $-0.27 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | $-0.48 | $-0.12 | ||
| Q4 24 | $-0.06 | $0.06 | ||
| Q3 24 | $-0.63 | $-0.13 | ||
| Q2 24 | $-2.57 | $-0.09 | ||
| Q1 24 | $-0.11 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.4M | $4.1M |
| Total Assets | $6.0M | $17.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.5M | — | ||
| Q3 25 | $3.1M | $3.6M | ||
| Q2 25 | — | $78.5K | ||
| Q1 25 | $3.1M | $179.1K | ||
| Q4 24 | $2.4M | $533.9K | ||
| Q3 24 | $2.8M | $2.1M | ||
| Q2 24 | $4.2M | $2.7M | ||
| Q1 24 | $5.3M | $5.2M |
| Q4 25 | $4.4M | — | ||
| Q3 25 | $5.2M | $4.1M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | $5.5M | $6.8M | ||
| Q4 24 | $5.1M | $10.2M | ||
| Q3 24 | $5.3M | $9.7M | ||
| Q2 24 | $6.6M | $10.3M | ||
| Q1 24 | $7.8M | $12.4M |
| Q4 25 | $6.0M | — | ||
| Q3 25 | $6.9M | $17.5M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | $7.4M | $16.0M | ||
| Q4 24 | $7.3M | $17.2M | ||
| Q3 24 | $7.9M | $10.6M | ||
| Q2 24 | $9.3M | $11.1M | ||
| Q1 24 | $10.3M | $13.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-991.0K | $763.1K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-991.0K | — | ||
| Q3 25 | $-268.0K | $763.1K | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | $-1.0M | $-1.2M | ||
| Q4 24 | $-791.0K | $-6.5M | ||
| Q3 24 | $-1.3M | $632.7K | ||
| Q2 24 | $-1.0M | $-2.4M | ||
| Q1 24 | $-1.8M | $-866.3K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $589.6K | ||
| Q2 24 | $-1.1M | $-2.4M | ||
| Q1 24 | — | $-1.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | -95.5% | -388.0% | ||
| Q1 24 | — | -136.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | 2.1% | 5.1% | ||
| Q1 24 | 0.0% | 20.3% |
| Q4 25 | — | — | ||
| Q3 25 | -134.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
